Date Filed | Type | Description |
01/27/2023 |
4
| Dickinson Klara (Chief Regulatory Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 215,000 options to buy
@ $7.8, valued at
$1.7M
|
|
01/27/2022 |
4
| Dickinson Klara (Chief Regulatory Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 175,000 options to buy
@ $2.94, valued at
$514.5k
|
|
01/28/2021 |
4
| Dickinson Klara (Chief Regulatory Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 66,500 options to buy
@ $5.78, valued at
$384.4k
|
|
05/19/2020 |
4
| Dickinson Klara (See Remarks) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 328,299 options to buy
@ $4.05, valued at
$1.3M
|
|
01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/26/2018 |
4
| Dickinson Klara (SVP, Regulatory and Quality) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 100,000 options to buy
@ $11.69, valued at
$1.2M
|
|
06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/25/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |